$251.03
2.350.94%
At Close: -
$251.03
00.00%
After Hours: 4:38 PM EDT
15 minutes delayed
Alnylam Pharmaceuticals
ALNYNASDAQ
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock, Earnings Estimates, EPS, And Revenue
Alnylam Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$-1.100
Quarterly Revenue Estimate
$446M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2B
Analyze the earnings history of Alnylam Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals | -$1.62 | -$1.10 | — | — | $318.75M | $445.98M | — | — | 08/01/2024 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.06 | -$1.18 | -$0.16 | 86.44% | $319.29M | $427.33M | $494.33M | 15.68% | 05/02/2024 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.39 | -$1.33 | -$0.77 | 42.11% | $335.04M | $442.90M | $439.72M | -0.72% | 02/15/2024 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.58 | -$1.36 | $1.74 | 227.94% | $264.31M | $401.03M | $750.53M | 87.15% | 11/02/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$2.03 | -$1.72 | -$1.62 | 5.81% | $224.82M | $331.73M | $318.75M | -3.91% | 08/03/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.49 | -$1.76 | -$1.06 | 39.77% | $213.26M | $312.26M | $319.29M | 2.25% | 05/04/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.74 | -$1.90 | -$1.39 | 26.84% | $258.54M | $313.13M | $335.04M | 7.00% | 02/23/2023 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.59 | -$1.78 | -$1.58 | 11.24% | $187.63M | $293.03M | $264.31M | -9.80% | 10/27/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.30 | -$1.62 | -$2.03 | -25.31% | $220.55M | $255.88M | $224.82M | -12.14% | 07/28/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.64 | -$1.84 | -$1.49 | 19.02% | $135.77M | $243.02M | $213.26M | -12.25% | 04/28/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.60 | -$1.54 | -$1.69 | -9.74% | $163.56M | $233.62M | $258.54M | 10.66% | 02/10/2022 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.58 | -$1.57 | -$1.51 | 3.82% | $125.85M | $218.69M | $187.63M | -14.20% | 10/28/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.67 | -$1.60 | -$1.30 | 18.75% | $103.96M | $193.18M | $220.55M | 14.17% | 08/03/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.52 | -$1.75 | -$1.64 | 6.29% | $99.48M | $168.74M | $177.57M | 5.23% | 04/29/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.98 | -$1.76 | -$1.60 | 9.09% | $71.68M | $146.07M | $163.56M | 11.98% | 02/11/2021 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.50 | -$1.66 | -$1.58 | 4.82% | $70.06M | $120.75M | $125.85M | 4.23% | 11/05/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.83 | -$1.74 | -$1.67 | 4.02% | $44.71M | $99.48M | $103.96M | 4.51% | 08/06/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.73 | -$1.89 | -$1.52 | 19.58% | $33.29M | $91.56M | $99.48M | 8.65% | 05/06/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.82 | -$2.23 | -$1.98 | 11.21% | $21.03M | $72.00M | $71.68M | -0.44% | 02/06/2020 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.56 | — | -$1.50 | — | $2.07M | — | $70.06M | — | 10/31/2019 | Get Alert |
| ALNY | Alnylam Pharmaceuticals | -$1.61 | -$1.86 | -$1.83 | 1.61% | $29.91M | $69.20M | $44.71M | -35.38% | 08/06/2019 | Get Alert |
Alnylam Pharmaceuticals (ALNY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.16 | $-1.18 | 86.4 % |
| Dec 2023 | 2024-02-15 | $-0.77 | $-1.33 | 42.1 % |
| Sep 2023 | 2023-11-02 | $1.74 | $-1.36 | 227.9 % |
| Jun 2023 | 2023-08-03 | $-1.62 | $-1.72 | 5.81 % |
Alnylam Pharmaceuticals (ALNY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $494.33M | $427.33M | 15.7 % |
| Dec 2023 | 2024-02-15 | $439.72M | $442.90M | -0.72 % |
| Sep 2023 | 2023-11-02 | $750.53M | $401.03M | 87.2 % |
| Jun 2023 | 2023-08-03 | $318.75M | $331.73M | -3.91 % |
FAQ
When is Alnylam Pharmaceuticals (NASDAQ:ALNY) reporting earnings?
Alnylam Pharmaceuticals (ALNY) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Alnylam Pharmaceuticals (NASDAQ:ALNY)?
The Actual EPS was $-0.16, which beat the estimate of $-1.18.
What were Alnylam Pharmaceuticals’s (NASDAQ:ALNY) revenues?
The Actual Revenue was $494.3M, which beat the estimate of $427.3M.
Browse earnings estimates, EPS, and revenue on all stocks.